Skip to content

Multiple Sclerosis Produces Cardiovascular Subclinical Dysfunction

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03001284
Enrollment
103
Registered
2016-12-23
Start date
2012-10-31
Completion date
2016-12-31
Last updated
2016-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Brief summary

Multiple sclerosis (MS), debilitating disease involving primarily the central nervous system, may cause cardiovascular dysfunction, due to autonomous nervous system dysfunction, physical invalidity, increased oxidative stress, and systemic inflammatory status, but the detailed mechanisms are not elucidated. The investigators aimed to assess left and right ventricular (LV and RV) function, left atrial (LA) function, arterial function, and atrial-ventricular-arterial coupling in patients with MS, compared to control subjects. LV systolic and diastolic function and RV function were assessed by 2D- and 3D- echocardiography, tissue Doppler, and speckle tracking echocardiography. LA function was assessed by LA volume index and LA strain. Arterial remodeling and stiffness were assessed by intima media-thickness, pulse wave velocity, and parameters of wave intensity and endothelial function

Interventions

OTHERNO intervention

Sponsors

Carol Davila University of Medicine and Pharmacy
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. age between 18 and 65 years; 2. patients with confirmed MS diagnosis, both newly diagnosed or already under immunomodulatory treatment; 3. informed consent signed.

Exclusion criteria

1. MS treated with mitoxantrone; 2. patients with known cardiovascular disease; 3. presence of other neurological conditions; 4. any renal, pulmonary, hepatic or hematological disease; 5. diabetes mellitus; 6. any degree of arterial hypertension; 7. pregnancy; 8. and difficult acoustic window

Design outcomes

Primary

MeasureTime frame
Left ventricle systolic dysfunction - by echocardiography1 year
Right ventricle systolic dysfunction- by echocardiography1 year
Left ventricular diastolic function - by echocardiography1 year
arterial function - by vascular echography1 year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026